First-In-Human Study of Apramycin

NCT04105205 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Apramycin injection
DRUG: Placebo injection

Sponsor

Juvabis AG

Collaborators

[object Object]